Metoclopramida [Inn-Spanish] en es it fr

Metoclopramida [Inn-Spanish] Brand names, Metoclopramida [Inn-Spanish] Analogs

Metoclopramida [Inn-Spanish] Brand Names Mixture

  • No information avaliable

Metoclopramida [Inn-Spanish] Chemical_Formula


Metoclopramida [Inn-Spanish] RX_link

Metoclopramida [Inn-Spanish] fda sheet

Metoclopramida_[Inn-Spanish] FDA

Metoclopramida [Inn-Spanish] msds (material safety sheet)

Metoclopramida_[Inn-Spanish] MSDS

Metoclopramida [Inn-Spanish] Synthesis Reference

Thominet, U.S. Pat. 3,177,252 (1965)

Metoclopramida [Inn-Spanish] Molecular Weight

299.796 g/mol

Metoclopramida [Inn-Spanish] Melting Point

147.25 oC

Metoclopramida [Inn-Spanish] H2O Solubility

200 mg/L

Metoclopramida [Inn-Spanish] State


Metoclopramida [Inn-Spanish] LogP


Metoclopramida [Inn-Spanish] Dosage Forms

Liquid; Syrup; Tablet

Metoclopramida [Inn-Spanish] Indication

For the treatment of gastroesophageal reflux disease (GERD)

Metoclopramida [Inn-Spanish] Pharmacology

Metoclopramide, although chemically related to procainamide, does not possess local anesthetic or antiarrhythmic properties. Metoclopramide is used to enhance GI motility, to treat diabetic gastroparesis, as an antinauseant, and to facilitate intubation of the small bowel during radiologic examination. Metoclopramide may be used to treat chemotherapy-induced emesis and as a radiosensitizing agents in the treatment of non-small cell lung carcinoma and glioblastomas in the future.

Metoclopramida [Inn-Spanish] Absorption

Rapidly and well absorbed (oral bioavailability 80±15.5%).

Metoclopramida [Inn-Spanish] side effects and Toxicity

Oral, mouse LD50: 280 mg/kg. Signs of overdose include drowsiness, disorientation, and extrapyramidal reactions.

Metoclopramida [Inn-Spanish] Patient Information

Metoclopramida [Inn-Spanish] Organisms Affected

Humans and other mammals